V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough

Thermo Fisher Scientific Executive Compensation (FY25)

TMO · Executive and director compensation, fiscal 2022 to 2025

The Thermo Fisher Scientific brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Data as of September 7, 2026Latest filing (8-K): May 26, 2026
13 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Thermo Fisher Scientific brief$1,500Get the executive brief
333 figures on this page: 325 cited to the filing that reported them, 8 calculated from figures it prints. See the citations
Chief executive, fiscal 2025
◇
Marc Casper
Latest say-on-pay support
=
May 20, 2026
Chief executive pay ratio
◇
To the median employee
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Marc Casper: $30,449,599 → $79,923,350 (162.5% higher)
CEO pay ratio: 403:1 → 1,120:1 (177.9% higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is Thermo Fisher Scientific's chief executive and what were they paid?
Marc Casper, Chairman, President and Chief Executive Officer, received $79,923,350 in total compensation for fiscal 2025. Casper's total was 162.5% higher than the $30,449,599 reported for fiscal 2024.
What was Thermo Fisher Scientific's say-on-pay result?
Shareholders supported the say-on-pay proposal with 31.8% of votes cast for or against in favor at the meeting held May 20, 2026 for fiscal 2025.
Which companies are in Thermo Fisher Scientific's peer group?
Companies named in the disclosed peer group include AbbVie Inc., Amgen Inc., Becton Dickinson and Company, Bristol-Myers Squibb and Broadcom Inc., among others. The 2025 TSR Peer Group includes 3M Company, AstraZeneca plc, Automatic Data Processing, Inc., Boston Scientific Corp. and CSX Corporation, among others.
What is Thermo Fisher Scientific's chief executive pay ratio?
For fiscal 2025, the company reported a chief executive pay ratio of 1,120:1, against median employee compensation of $71,333.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Marc Casper
Chairman, President and Chief Executive Officer
◇—◇◇◇—◇◇
Michel Lagarde
Executive Vice President and Chief Operating Officer
◇—◇◇◇—◇◇
Stephen Williamson
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Gianluca Pettiti
Executive Vice President
◇—◇◇◇—◇◇
Michael Boxer
Senior Vice President and General Counsel
◇—◇◇◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Marc Casper
Chairman, President and Chief Executive Officer
◇—◇◇◇—◇◇
Michel Lagarde
Executive Vice President and Chief Operating Officer
◇—◇◇◇—◇◇
Stephen Williamson
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Gianluca Pettiti
Executive Vice President
◇—◇◇◇—◇◇
Lisa Britt
Senior Vice President and Chief Human Resources Officer
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Marc Casper
Chairman, President and Chief Executive Officer
◇—◇◇◇—◇◇
Michel Lagarde
Executive Vice President and Chief Operating Officer
◇—◇◇◇—◇◇
Gianluca Pettiti
Executive Vice President
◇—◇◇◇—◇◇
Stephen Williamson
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Frederick Lowery
Executive Vice President
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Marc Casper
Chairman, President and Chief Executive Officer
◇—◇◇◇—◇◇
Michel Lagarde
Executive Vice President and Chief Operating Officer
◇—◇◇◇—◇◇
Gianluca Pettiti
Executive Vice President
◇—◇◇◇—◇◇
Stephen Williamson
Senior Vice President and Chief Financial Officer
◇—◇◇◇—◇◇
Frederick Lowery
Executive Vice President
◇—◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Frederick LoweryPSU◇—————◇
Frederick LoweryOPTION◇——◇—◇◇
Frederick LoweryRSU◇——◇——◇
Gianluca PettitiRSU◇——◇——◇
Gianluca PettitiOPTION◇——◇—◇◇
Gianluca PettitiPSU◇—————◇
Marc CasperPSU◇—◇—◇—◇
Marc CasperPSU◇—————◇
Marc CasperOPTION◇——◇—◇◇
Michel LagardePSU◇—————◇
Michel LagardeRSU◇——◇——◇
Michel LagardeOPTION◇——◇—◇◇
Stephen WilliamsonRSU◇——◇——◇
Stephen WilliamsonPSU◇—————◇
Stephen WilliamsonOPTION◇——◇—◇◇
Fiscal 2022, 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Michel LagardeOption◇—◇9/5/2026
RSU◇◇——
Option◇—◇2/25/2027
RSU◇◇——
Option◇—◇2/23/2028
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇9/9/2027
Stephen WilliamsonRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇9/9/2027
Option◇—◇2/25/2027
Option◇—◇2/23/2028
Gianluca PettitiOption◇—◇9/9/2027
Option◇—◇2/25/2027
RSU◇◇——
Option◇—◇2/23/2028
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Frederick LoweryOption◇—◇9/9/2027
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/25/2027
RSU◇◇——
Option◇—◇2/23/2028
RSU◇◇——
Marc CasperOption◇—◇2/25/2027
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/23/2028
Option◇—◇9/9/2027
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Scott M. Sperling
Lead independent director
◇◇———◇◇
Karen S. Lynch
◇◇———◇◇
Nelson J. Chai
◇◇———◇◇
Tyler Jacks
◇◇———◇◇
Debora L. Spar
◇◇———◇◇
Dion J. Weisler
◇◇———◇◇
C. Martin Harris
◇◇———◇◇
Jennifer M. Johnson
◇◇———◇◇
Ruby R. Chandy
◇◇———◇◇
R. Alexandra Keith
◇◇———◇◇
James C. Mullen
◇◇———◇◇
Marc N. Casper served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • AbbVie Inc. ABBV
  • Amgen Inc. AMGN
  • Becton Dickinson and Company BDX
  • Bristol-Myers Squibb BMY
  • Broadcom Inc. AVGO
  • Cisco Systems, Inc. CSCO
  • Danaher Corp DHR
  • Eli Lilly and Company LLY
  • Gilead Sciences Inc. GILD
  • Honeywell International Inc. HON
  • Johnson & Johnson JNJ
  • Medtronic, plc MDT
  • Merck & Co, Inc. MRK
  • NIKE, Inc. NKE
  • PepsiCo, Inc. PEP
  • Pfizer, Inc. PFE
  • Texas Instruments Inc. TXN
  • The Procter & Gamble Co. PG
2025 TSR Peer Group
  • 3M Company MMM
  • AstraZeneca plc AZN
  • Automatic Data Processing, Inc. ADP
  • Boston Scientific Corp. BSX
  • CSX Corporation CSX
  • IQVIA Holdings Inc. IQV
  • Merck KGaA MRK.DE
  • Stryker Corporation SYK
  • The Boeing Company BA
  • The PNC Financial Services Group, Inc. PNC

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 20, 2026=◇◇◇
2024May 21, 2025=◇◇◇
2023May 22, 2024=◇◇◇
2022May 24, 2023=◇◇◇
2021May 18, 2022=◇◇◇
2020May 19, 2021=◇◇◇
2019May 20, 2020=◇◇◇
2018May 22, 2019=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇
Email me this page as a cited PDF
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Thermo Fisher Scientific files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Thermo Fisher Scientific disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Thermo Fisher Scientific sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $1,200
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Say-on-pay responsiveness
Thermo Fisher Scientific recorded a low support level. The responsiveness analysis covers what the company said it would do, what it did, and how that compares with the companies that recovered their vote.
Responsiveness analysis
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for a Velarion Pro seat
Full platform access for one person: every industry we cover, peer positioning, and the written analysis. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.
Join the list for Peer Group Review
Whether Thermo Fisher Scientific's disclosed peer group is defensible, who names Thermo Fisher Scientific back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
333 figures on this page: 325 cited to the filing that reported them, 8 calculated from figures it prints.
325 cited to the filing
8 calculated from the filing

Documents cited

  1. 0000097745-26-000117
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001193125-26-144585
    Director compensation table · Grants of Plan-Based Awards · Outstanding equity awards at 2025 fiscal year-end · Summary compensation table
  3. 000119312526144585
    CEO Pay Ratio
  4. 0000097745-25-000069
    Item 5.07 Submission of Matters to a Vote of Security Holders
  5. 0001193125-25-075101
    Summary compensation table
  6. 0000097745-24-000026
    Item 5.07 Submission of Matters to a Vote of Security Holders
  7. 0001193125-24-090173
    Summary compensation table
  8. 0000097745-23-000042
  9. 0000097745-23-000025
    Summary compensation table
  10. 0000097745-22-000032
    Item 5.07 Submission of Matters to a Vote of Security Holders
  11. 0000097745-21-000028
    Item 5.07 Submission of Matters to a Vote of Security Holders
  12. 0000097745-20-000023
    Item 5.07 Submission of Matters to a Vote of Security Holders
  13. 0000097745-19-000018
    Item 5.07 Submission of Matters to a Vote of Security Holders
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Thermo Fisher Scientific executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/TMO (accessed 2026).
Short form: data: Velarion

The Thermo Fisher Scientific brief, $1,500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
Both reports for $2,400.
Get the executive briefGet the board briefNo account needed.
13 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Thermo Fisher Scientific and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

Peers Thermo Fisher Scientific discloses

The companies named in TMO's own disclosed peer group.

AbbVie Inc.Amgen Inc.Becton Dickinson and CompanyBristol-Myers SquibbBroadcom Inc.Cisco Systems, Inc.Danaher CorpEli Lilly and CompanyGilead Sciences Inc.Honeywell International Inc.Johnson & JohnsonMedtronic, plcMerck & Co, Inc.NIKE, Inc.PepsiCo, Inc.Pfizer, Inc.Texas Instruments Inc.The Procter & Gamble Co.3M CompanyAutomatic Data Processing, Inc.Boston Scientific Corp.CSX CorporationIQVIA Holdings Inc.Stryker Corporation

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy